SynopsisMumbai-based B2B pharma distribution platform Fundly.ai has raised $4 million from existing investors Accel and Multiply, along with venture debt of $0.9 million. Founded in 2021, Fundly started as a supply-chain finance platform for pharma companies but has since expanded into three interconnected businesses: B2B commerce, transaction and settlement infrastructure, and embedded credit.Mumbai-based Fundly.ai, a B2B pharma distribution platform, has raised $4 million in a round led by existing investors Accel and Multiply, as it looks to expand its digital commerce, payments, and credit offerings across India’s pharma supply chain.The round also saw participation from former RBL Bank executive director Rajeev Ahuja and a group of angel investors. Besides the equity, the company also raised venture debt of around $0.9 millionNow Playing